RE: COPD Research/Trial27 Aug 2020 17:55
Meelie,
I haven’t had time to catch up with posts so forgive me with my late addition.....it maybe a repeat.
When Astra pulled out.....Synairgen were later able to reanalyse the results. They could show yes...that some of the patients had bacterial rather than viral infections which of course.....diluted the affect. Additionally, though, because it was unknown at the time, many of the patients were on steroid treatments as a norm. This counters the affect of Synairgen. Hence it was a faulted trial......